Signet Healthcare Partners
Growth equityNew York · Growth–Late Stage · 13 people tracked
Also known as SIGNET HEALTHCARE MANAGEMENT LLC · Signet Healthcare Partners Accredited Partnership · Signet Healthcare Partners QP Partnership
Investment thesis
Signet Healthcare Partners invests growth capital in commercial-stage healthcare companies that are either revenue-generating or preparing for commercial launch, concentrating primarily on the pharmaceutical and medical device sectors. The firm actively partners with management teams to support growth and build successful businesses. Over a 25-year history, it has raised funds with total capital commitments exceeding $600 million and has invested in more than 55 companies globally.
Source: firm website, verified Aug 11, 2026.
Team · 13 people
from the firm's website & public directories
What they invest in
from 37 of 59 portfolio companiesBiotech ×25Healthtech ×17Medical Devices ×16Deep Tech ×4Advanced Manufacturing ×3AI & Machine Learning ×2Digital Health ×2Circular Economy ×1
HQs:United States×19Canada×2Switzerland×1Denmark×1United Kingdom×1Mexico×1
Investments · 59 tracked
founders shown can be your intro pathBy year:2025 · 12023 · 12022 · 12021 · 22020 · 22016 · 12015 · 210 dated
Ascendia Pharmaceutical Solutions is a contract development and manufacturing organization (CDMO) that provides formulation, nanotechnology, and manufacturing services for pharmaceutical and biological companies from pre-formulation through commercialization.
Advanced ManufacturingBiotechHealthtechMedical DevicesNorth Brunswick, US
Jingjun Huang(Executive Officer, Director)
BoardRobert Bloder(Director)Michael Bogda(Director)Shoufeng Li(Director)Theron Odlaug(Director)
Board seatJames Gale· per SEC Form D
Cerium Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for rare kidney diseases, with a lead program (SNP-ACTH (1-39) Gel) targeting Primary Membranous Nephropathy (PMN).
BiotechHealthtechGaithersburg, US
Gregg Lapointe(Executive Officer, Director)Gregg A. Lapointe(Executive Officer, Director)Peter Collum(Director)Steve Eskenazi(Director)Robert Rubin(Director)Tom DePasquale(Director)
Board seatJames Gale· per SEC Form D · $10.1M raise · filed Jul 2021
Hologic develops medical technologies for women's health that detect, diagnose and treat health conditions across multiple countries.
FemTechHealthtechMedical DevicesRedwood City, US
Ken Haas(Director)Karen Talmadge(Director)Doug Fisher(Director)Christopher Owens(Executive Officer, Director)Chandra P. Leo(Director)
BoardJonathan MacQuitty(Director)
Board seatJoyce Erony· per SEC Form D · $50M raise · filed Dec 2021
BiotechSunnyvale, US
David Tierney(Executive Officer, Director)Song Toja(Director)William White(Director)Michael Hemric(Director)
Board seatJoyce Erony· per SEC Form D
BiotechDublin 2
Jason Spees(Executive Officer, Director)Shlomi Nachman(Director)Paul Bae(Executive Officer)Konstantin Poukalov(Director)Robert Faulkner(Director)Shlomo Ben-Haim(Director)
Board seatJoyce Erony· per SEC Form D · $60M raise · filed Jan 2021
Neuros Medical develops the Altius Direct Electrical Nerve Stimulation System, an FDA-approved implantable device for managing chronic phantom limb pain and residual limb pain in adults with lower limb loss.
BiotechHealthtechMedical DevicesAliso Viejo, US
David Veino(President, Chief Executive Officer, and Secretary)Zach Stassen(Chief Financial Officer)Claiborne R. Rankin(Director)Robert J. Centa(Chief Financial Officer)Joseph J. Jankowski(Director)Scott F. Drees(Director)
Board seatJoyce Erony· per SEC Form D · $42.8M raise · filed Nov 2020
BiotechHunt Valley, US
Syed E Abidi, Ph.D.(Director)John Fowler(Executive Officer, Director)Syed E. Abidi(Executive Officer, Director)Sana I. Abidi(Director)Julien Hecht(Executive Officer)Shahid Raza(Director)
Board seatJames Gale· per SEC Form D · $4.2M raise · filed Mar 2024
Altasciences is a contract research organization providing biopharmaceutical companies with preclinical safety testing, clinical pharmacology trials, bioanalysis, and manufacturing and analytical services to accelerate early phase drug development.
BiotechHealthtechMedical Devices
Curia is a CDMO (Contract Development and Manufacturing Organization) providing drug discovery, development, and manufacturing services across small molecules, generic APIs, sterile drug products, and biologics for biopharma companies.
BiotechEnterprise Software
Merz Aesthetics, Anteis SA develops and manufactures biomedical products for aesthetic medicine, including injectable fillers, resorbable implants, and skin hydration gels.
Medical DevicesPlan-les-Ouates, CH
BiotechSomerset, US
Albert Friesen(Executive Officer, Director)Vithal Dahduk(Director)Timothy B. Sawyer(Director)Ravishanker Kovi(Executive Officer, Director)Theron E. Odlaug(Director)Todd Sone(Director)
Azurity Pharmaceuticals develops and commercializes pharmaceutical medicines across multiple therapeutic areas for patients globally.
BiotechDigital HealthHealthtechWoburn, US
BiotechPrinceton, US
Gaurav Mehrotra(Executive Officer)Carol S. Ben-Maimon(Director)Richard Van Duyne(Director)David W. Goodman(Director)Venkatachalam Krishnan(Executive Officer, Director)Lavesh Samtani(Executive Officer)
BiotechClearwater, US
RONALD L MILLER(Director, Promoter)MARK J LICARDE(Executive Officer, Director, Promoter)BRIAN MCMILLAN(Executive Officer, Director, Promoter)TODD R DAVIAU(Executive Officer, Director, Promoter)
Keenova is a specialty therapeutics company focused on rare, stigmatized, or unaddressed conditions across areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.
BiotechHealthtechMedical DevicesMalvern, US
Scott Hirsch(Director)Paul Efron(Director)Paul Herendeen(Director)Marc Yoskowitz(Director)Patrick Barry(Executive Officer)Blaise Coleman(President; Chief Executive Officer)
Medtronic designs and develops medical technology for treating complex diseases.
AI & Machine LearningDigital HealthHealthtechMedical Devices
BiotechMontreal, CA
LEON develops precision nanoparticle manufacturing systems powered by patented FR-JET® mixing technology, serving pharmaceutical and biotech companies transitioning from research and development to GMP production.
BiotechDeep TechMedical Devices
Keenova Therapeutics is a specialty pharmaceutical company developing treatments for rare, stigmatized, or unaddressed conditions across therapeutic areas including immunology, urology, hepatology, ophthalmology, orthopedics, and critical care.
BiotechHealthtechMedical Devices
Dowds is a UK-based engineering company providing integrated technical solutions and design-led project delivery for complex built environments, with particular expertise in healthcare infrastructure, mechanical, electrical, and building systems integration.
Construction TechHealthtechUK, GB
Paragonix Technologies provides organ preservation and transport technology with controlled temperature systems and digital tracking for donor organs, serving transplant centers and procurement teams.
HealthtechMedical DevicesCambridge, US
DeWitt Davenport(Director)John Cammett(Director)Carl Rickenbaugh(Director)Alexander Arrow(Director)John McDermott(Director)Lisa Anderson(Executive Officer, Director)
Complex sterile injectables CDMO
RK Pharma Inc develops and manufactures affordable generic pharmaceutical products, including injectables, sterile ophthalmic, dermal, and oral dosage forms.
BiotechHealthtechNew Jersey, US
SMART Medical Systems develops the G-EYE® balloon colonoscope, a medical device for gastroenterology that assists physicians in polyp detection and removal during endoscopy procedures.
Medical Devices
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 1
IPOs and acquisitions across the tracked portfolioTELA BioNASDAQ: TELA
Portfolio news
latest coverage across their companiesNeuros Medical · finance.yahoo.com · Jul 10, 2025
Frequently asked questions
- What stage does Signet Healthcare Partners invest at?
- Signet Healthcare Partners invests at the Growth, Late Stage stages.
- What is Signet Healthcare Partners's typical check size?
- Signet Healthcare Partners typically writes checks of $10M – $50M.
- What sectors does Signet Healthcare Partners focus on?
- Signet Healthcare Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Signet Healthcare Partners located?
- Signet Healthcare Partners is headquartered in New York, US.
- Does Signet Healthcare Partners lead rounds?
- Yes, Signet Healthcare Partners leads investment rounds.
Co-investors · 5
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Aperture Venture Partners is a healthcare-focused investment firm that backs entrepreneurs building companies in medical devices, pharmaceuticals, healthcare IT/services, and diagnostics.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
OUP (Osage University Partners) is a venture capital firm that backs science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.
Firms observed investing alongside Signet Healthcare Partners, from public investor directories. Shared companies are the overlap with Signet Healthcare Partners's recorded portfolio.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.